Pure Global AI
NCT06400927Not yet recruiting

Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure

Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure: A Randomized Controlled Pilot Study: ASSIST-HF SIRIO
East and North Hertfordshire NHS TrustClinicalTrials.govother
Verified
Study focus
Disease/Condition
Heart Failure
Drug/Device/Intervention
HF-guided VA
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
East and North Hertfordshire NHS Trust
Timeline & enrollment
Phase
N/A
Start date
Jun 13, 2024
End date
Sep 13, 2027
Enrollment
60 participants
Primary outcome

Acceptability of the intervention to users (participants)

Summary

The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual
 assistant (VA) into the outpatient management of participants recently discharged from
 hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical
 assessment and the healthcare burden, reduce variability in healthcare, and meet with
 participant satisfaction, without compromising participant safety and overall care quality.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06400927
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06400927 through Pure Global AI's free database. This phase not specified trial is sponsored by East and North Hertfordshire NHS Trust and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.